Indian Shares Decline Amid Geopolitical Tensions; TCS Shares Down Nearly 2%
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jan 08 2026
0mins
Should l Buy ?
Source: NASDAQ.COM
- Market Decline: Indian benchmark BSE Sensex fell by 155 points, or 0.2%, amid rising geopolitical tensions and trade uncertainties, indicating a decline in investor sentiment that could impact future market confidence.
- Major Stock Performance: TCS shares dropped nearly 2%, while Tech Mahindra, Reliance Industries, and Infosys saw declines of around 1%, reflecting overall market weakness that may lead investors to reassess these companies' growth prospects.
- Individual Company Dynamics: Meesho's stock plummeted 4.3% following the resignation of its general manager, highlighting how management changes can negatively affect company operations and exacerbate market concerns about its future performance.
- Regulatory Approval: Gland Pharma's shares rose by 1.4% after receiving FDA approval for its Olopatadine Hydrochloride Ophthalmic Solution, indicating progress in new drug development that could support future revenue growth.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
